CalciMedica
CALC
12 hedge funds and large institutions have $2.72M invested in CalciMedica in 2023 Q2 according to their latest regulatory filings, with 12 funds opening new positions, increasing their positions, reducing their positions, and 0 closing their positions.
2.4% more ownership
Funds ownership: 0% → 2.4% (+2.4%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
O
OrbiMed
New York
|
+$1.3M |
| 2 |
DM
Deerfield Management
New York
|
+$1.16M |
| 3 |
BCM
BML Capital Management
Zionsville,
Indiana
|
+$388K |
| 4 |
First Manhattan
New York
|
+$57.8K |
| 5 |
MPM
Meritage Portfolio Management
Overland Park,
Kansas
|
+$43.7K |
Top Sellers
CALC Hedge Fund Activity: Q2 2023 in Review
12 of the 6,383 institutional investors tracked by Wall St. Rank reported a position in CalciMedica (CALC) for Q2 2023, worth a combined $2.72M.
Buyers outnumbered sellers: 12 funds opened new CALC positions and 0 closed out — a net gain of 12 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was OrbiMed, opening a new position worth an estimated $1.3M.
- 12 institutional investors held CalciMedica (CALC) as of Q2 2023, up from 0 in Q1 2023.
- Funds reported $2.72M of CalciMedica stock for Q2 2023.
- 12 funds opened new CalciMedica positions in Q2 2023 and 0 closed out, a net change of +12 holders.
- The largest CalciMedica buyer in Q2 2023 was OrbiMed, an estimated $1.3M added.
Based on aggregated 13F filings for Q2 2023.